For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Merit Medical Systems, Inc (NASDAQ: MMSI) closed at $86.39 down -0.23% from its previous closing price of $86.59. In other words, the price has decreased by -$0.23 from its previous closing price. On the day, 0.53 million shares were traded. MMSI stock price reached its highest trading level at $87.47 during the session, while it also had its lowest trading level at $86.16.
Ratios:
For a deeper understanding of Merit Medical Systems, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.76. For the most recent quarter (mrq), Quick Ratio is recorded 2.86 and its Current Ratio is at 4.28. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
In the most recent recommendation for this company, JP Morgan on March 28, 2025, initiated with a Overweight rating and assigned the stock a target price of $120. On December 11, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $103 to $120. On June 28, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $96.Robert W. Baird initiated its Outperform rating on June 28, 2024, with a $96 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 25 ’25 when Lampropoulos Fred P. sold 10,000 shares for $88.04 per share. The transaction valued at 880,377 led to the insider holds 1,019,955 shares of the business.
FRED LAMPROPOULOS bought 10,000 shares of MMSI for $880,377 on Nov 25 ’25. On Nov 21 ’25, another insider, Lampropoulos Fred P., who serves as the Executive Chairman of the company, sold 25,000 shares for $87.31 each. As a result, the insider received 2,182,750 and left with 1,029,955 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MMSI now has a Market Capitalization of 5122084352 and an Enterprise Value of 5550779392. As of this moment, Merit’s Price-to-Earnings (P/E) ratio for their current fiscal year is 44.22, and their Forward P/E ratio for the next fiscal year is 21.54. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.41. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.47 while its Price-to-Book (P/B) ratio in mrq is 3.35. Its current Enterprise Value per Revenue stands at 3.758 whereas that against EBITDA is 19.024.
Stock Price History:
The Beta on a monthly basis for MMSI is 0.62, which has changed by -0.17582524 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, MMSI has reached a high of $111.45, while it has fallen to a 52-week low of $78.12. The 50-Day Moving Average of the stock is 2.61%, while the 200-Day Moving Average is calculated to be -5.35%.
Shares Statistics:
For the past three months, MMSI has traded an average of 651.93K shares per day and 672390 over the past ten days. A total of 59.29M shares are outstanding, with a floating share count of 57.85M. Insiders hold about 2.43% of the company’s shares, while institutions hold 103.52% stake in the company. Shares short for MMSI as of 1763078400 were 2921809 with a Short Ratio of 4.48, compared to 1760486400 on 3334692. Therefore, it implies a Short% of Shares Outstanding of 2921809 and a Short% of Float of 6.94.
Earnings Estimates
. The current rating of Merit Medical Systems, Inc (MMSI) is the result of assessments by 10.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $0.89, with high estimates of $0.95 and low estimates of $0.81.
Analysts are recommending an EPS of between $3.75 and $3.65 for the fiscal current year, implying an average EPS of $3.73. EPS for the following year is $4.03, with 10.0 analysts recommending between $4.2 and $3.87.
Revenue Estimates
A total of 11 analysts believe the company’s revenue will be $388.35M this quarter.It ranges from a high estimate of $390.6M to a low estimate of $386.4M. As of. The current estimate, Merit Medical Systems, Inc’s year-ago sales were $355.16MFor the next quarter, 11 analysts are estimating revenue of $378.57M. There is a high estimate of $385.75M for the next quarter, whereas the lowest estimate is $369M.
A total of 11 analysts have provided revenue estimates for MMSI’s current fiscal year. The highest revenue estimate was $1.51B, while the lowest revenue estimate was $1.5B, resulting in an average revenue estimate of $1.51B. In the same quarter a year ago, actual revenue was $1.36BBased on 11 analysts’ estimates, the company’s revenue will be $1.6B in the next fiscal year. The high estimate is $1.62B and the low estimate is $1.57B.
